Skip to search formSkip to main contentSkip to account menu

YM17E

Known as: YM 17E 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Phenylurea Compounds

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2009
2009
Pharmacokinetic properties of YM17E, an inhibitor of acyl coenzyme A: cholesterol acyl transferase, and serum cholesterol levels in healthy volunteers
We conducted a single and repeat oral dose study of YM17E, a novel inhibitor of acyl coenzyme A (CoA): cholesterol… 
1997
1997
Pharmacological properties of YM17E, an acyl-CoA:cholesterol acyltransferase inhibitor, and diarrheal effect in beagle dogs.
YM17E (1,3-bis[[1-cycloheptyl-3-(p-dimethylaminophenyl)ureido]methyl]ben zene dihydrochloride) was found to be a potent inhibitor… 
1996
1996
In‐vitro Metabolism of YM17E, an Inhibitor of Acyl Coenzyme A: Cholesterol Acyltransferase, by Liver Microsomes in Man
Because YM17E (1,3‐bis[[1‐cycloheptyl‐3‐(p‐dimethylaminophenyl)ureido]methyl]benzene dihydrochloride) inhibits acyl coenzyme A… 
1994
1994
Disposition and metabolism of a novel diurea inhibitor of acyl CoA: cholesterol acyltransferase (YM17E) in the rat and dog.
1. We have investigated the disposition and metabolism of YM17E after intravenous and oral administration in the rat and dog. 2… 
1993
1993
Simultaneous determination of a new inhibitor of acyl CoA:cholesterol acyltransferase, YM17E, and five metabolites using high-performance liquid chromatography with electrochemical detection.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)